Literature DB >> 8077325

A simplified morning ovine corticotropin-releasing hormone stimulation test for the differential diagnosis of adrenocorticotropin-dependent Cushing's syndrome.

L K Nieman1, E H Oldfield, R Wesley, G P Chrousos, D L Loriaux, G B Cutler.   

Abstract

The objective of this study was to develop criteria for the interpretation of a morning ovine CRH stimulation test for the differential diagnosis of ACTH-dependent Cushing's syndrome. Its design was retrospective review, and its setting was the in-patient unit of a tertiary care center. One hundred and eighteen patients with proven Cushing's disease or ectopic ACTH secretion were studied. The percent change in plasma ACTH and cortisol levels after CRH administration (1 microgram/kg BW) was calculated for each patient using 3 combinations of pre-CRH values (-15, -10, -5, and -1 min) and 6 combinations of post-CRH values (15, 30, 45, and 60 min). The diagnostic performance of these 36 sets of response measures was compared. The mean ACTH concentrations 15 and 30 min after CRH increased by at least 35% above the mean basal value at -5 and -1 min in 93 of 100 patients with Cushing's disease, but in none of the 16 patients with ectopic ACTH secretion. This measure gave the best sensitivity (93%) and specificity (100%). The best cortisol criterion was a mean increase at 30 and 45 min of 20% or more above mean basal values at -5 and -1 min, which gave a sensitivity of 91% and a specificity of 88%. We developed a simplified diagnostic test with 100% specificity using ACTH measurements 5 and 1 min before and 15 and 30 min after CRH administration. Although all patients with ectopic ACTH secretion had less than a 35% increase in ACTH, the probability of Cushing's disease was high at all levels of response, indicating that other tests should be performed to confirm the diagnosis.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8077325     DOI: 10.1210/jcem.77.5.8077325

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  35 in total

Review 1.  [Cushing syndrome: diagnosis and therapy].

Authors:  F Beuschlein; W Arlt; B Allolio
Journal:  Med Klin (Munich)       Date:  1999-07-15

2.  Neuroendocrine ACTH-producing tumor of the thymus--experience with 12 patients over 25 years.

Authors:  Nicola M Neary; Ariel Lopez-Chavez; Brent S Abel; Alison M Boyce; Nicholas Schaub; King Kwong; Constantine A Stratakis; Cesar A Moran; Giuseppe Giaccone; Lynnette K Nieman
Journal:  J Clin Endocrinol Metab       Date:  2012-04-16       Impact factor: 5.958

3.  A comparison of immunometric and radioimmunoassay measurement of ACTH for the differential diagnosis of Cushing's syndrome.

Authors:  J R Lindsay; V K Shanmugam; E H Oldfield; A T Remaley; L K Nieman
Journal:  J Endocrinol Invest       Date:  2006-12       Impact factor: 4.256

Review 4.  Dynamic testing in Cushing's syndrome.

Authors:  Blerina Kola; Ashley B Grossman
Journal:  Pituitary       Date:  2008       Impact factor: 4.107

5.  Use of radioguided surgery with [111In]-pentetreotide in the management of an ACTH-secreting bronchial carcinoid causing ectopic Cushing's syndrome.

Authors:  E Grossrubatscher; F Vignati; P Dalino; M Possa; P A Belloni; A Vanzulli; M Bramerio; A Marocchi; O Rossetti; F Zurleni; P Loli
Journal:  J Endocrinol Invest       Date:  2005-01       Impact factor: 4.256

Review 6.  Diagnosis and management of pediatric adrenal insufficiency.

Authors:  Ahmet Uçar; Firdevs Baş; Nurçin Saka
Journal:  World J Pediatr       Date:  2016-04-08       Impact factor: 2.764

7.  Cushing's syndrome in multiple endocrine neoplasia type 1.

Authors:  William F Simonds; Sarah Varghese; Stephen J Marx; Lynnette K Nieman
Journal:  Clin Endocrinol (Oxf)       Date:  2012-03       Impact factor: 3.478

Review 8.  Diagnosis of Cushing's disease.

Authors:  Eleni Daniel; John D C Newell-Price
Journal:  Pituitary       Date:  2015-04       Impact factor: 4.107

Review 9.  Cushing's disease.

Authors:  Martina De Martin; Francesca Pecori Giraldi; Francesco Cavagnini
Journal:  Pituitary       Date:  2006       Impact factor: 4.107

10.  Acylated ghrelin as provocative test for the diagnosis of ACTH deficiency in patients with hypothalamus-pituitary disease.

Authors:  Valentina Gasco; Alessandro Berton; Mirko Parasiliti Caprino; Ioannis Karamouzis; Mauro Maccario; Ezio Ghigo; Silvia Grottoli
Journal:  Endocrine       Date:  2014-12-09       Impact factor: 3.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.